Barings LLC Jazz Pharmaceuticals PLC Transaction History

Barings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $281,367 - $384,538	-2,668 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $7,106 - $12,371	81 Added 3.13%	2,668 $266,000
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $272,124 - $355,577	-2,313 Reduced 47.2%	2,587 $385,000
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $167,741 - $191,941	1,340 Added 37.64%	4,900 $628,000
Q2 2019 Aug 12, 2019	SELL	$125.55 - $144.48 $1.31 Million - $1.51 Million	-10,430 Reduced 74.55%	3,560 $508,000
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $1.02 Million - $1.2 Million	8,380 Added 149.38%	13,990 $2 Million
Q2 2018 Aug 03, 2018	BUY	$146.33 - $183.18 $820,911 - $1.03 Million	5,610 New	5,610 $967,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.88B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.